Down syndrome screening marker levels in women with a previous aneuploidy pregnancy

This publication has 22 references indexed in Scilit:

• The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy
  Prenatal Diagnosis, 2004
• Centre‐specific ultrasound nuchal translucency medians needed for Down syndrome screening
  Prenatal Diagnosis, 2003
• Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance
  Prenatal Diagnosis, 2002
• Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisited
  Prenatal Diagnosis, 2002
• Between pregnancy biological variability of first trimester markers of Down syndrome: implications for screening in subsequent pregnancies
  Prenatal Diagnosis, 2001
• The influence of parity and gravidity on first trimester markers of chromosomal abnormality
  Prenatal Diagnosis, 2000
• Letter. Correct estimation of parameters for ultrasound nuchal translucency screening
  Prenatal Diagnosis, 1998
• Why it is necessary to study the role of mitochondrial genome in Trisomy 21 Pathogenesis
  Down Syndrome Research and Practice, 1998
• Maternal serum markers levels in consecutive pregnancies: A possible genetic predisposition to abnormal levels
  American Journal of Medical Genetics, 1996
• Maternal serum thyroid antibodies in early pregnancy and fetal Down's syndrome
  Prenatal Diagnosis, 1988